Abstract
Since their establishment in the early 1970s, the nuclear changes upon apoptosis induction, such as the condensation of chromatin, disassembly of nuclear scaffold proteins and degradation of DNA, were, and still are, considered as the essential steps and hallmarks of apoptosis. These are the characteristics of the execution phase of apoptotic cell death. In addition, accumulating data clearly show that some nuclear events can lead to the induction of apoptosis. In particular, if DNA lesions resulting from deregulation during the cell cycle or DNA damage induced by chemotherapeutic drugs or viral infection cannot be efficiently eliminated, apoptotic mechanisms, which enable cellular transformation to be avoided, are activated in the nucleus. The functional heterogeneity of the nuclear organization allows the tight regulation of these signaling events that involve the movement of various nuclear proteins to other intracellular compartments (and vice versa) to initiate and govern apoptosis. Here, we discuss how these events are coordinated to execute apoptotic cell death.
Similar content being viewed by others
References
Kerr JFR, Wyllie AH, Currie ARD (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257
Skalka M, Matyasova J, Cejkova M (1976) DNA in chromatin of irradiated lymphoid tissues degrades in vivo into regular fragments. FEBS Lett 72:271–275
Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555–556
Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44:817–829. doi:10.1016/0092-8674(86)90004-8
Jacobson MD, Burne JF, Raff MC (1994) Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899–1910
Schulze-Osthoff K, Walczak H, Dröge W, Krammer PH (1994) Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15–20. doi:10.1083/jcb.127.1.15
Zhivotovsky B, Samali A, Gahm A, Orrenius S (1999) Caspases : their intracellular localization and translocation during apoptosis. Cell Death Differ 6:644–651
Ferri KF, Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255–E263. doi:10.1038/ncb1101-e255
Galluzzi L, Bravo-San Pedro JM, Kroemer G (2014) Organelle-specific initiation of cell death. Nat Cell Biol 16:728–736. doi:10.1038/ncb3005
Parrish AB, Freel CD, Kornbluth S (2013) Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a008672
Zamaraev AV, Kopeina GS, Zhivotovsky B, Lavrik IN (2015) Cell death controlling complexes and their potential therapeutic role. Cell Mol Life Sci 72:505–517. doi:10.1007/s00018-014-1757-2
Gillies LA, Kuwana T (2014) Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem 115:632–640. doi:10.1002/jcb.24709
Marabese M, Mazzoletti M, Vikhanskaya F, Broggini M (2008) HtrA2 enhances the apoptotic functions of p73 on bax. Cell Death Differ 15:849–858. doi:10.1038/cdd.2008.7
Bouchier-Hayes L, Oberst A, McStay GP et al (2009) Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell 35:830–840. doi:10.1016/j.molcel.2009.07.023
Baliga BC, Read SH, Kumar S (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ 11:1234–1241. doi:10.1038/sj.cdd.4401492
Aksenova VI, Bylino OV, Zhivotovsky BD, Lavrik IN (2013) Caspase-2: what do we know today? Mol Biol 47:165–180. doi:10.1134/S0026893313010020
Vandenabeele P, Orrenius S, Zhivotovsky B (2005) Serine proteases and calpains fulfill important supporting roles in the apoptotic tragedy of the cellular opera. Cell Death Differ 12:1219–1224. doi:10.1038/sj.cdd.4401719
Tang J, Xie W, Yang X (2005) Association of caspase-2 with the promyelocytic leukemia protein nuclear bodies. Cancer Biol Ther 4:645–649. doi:10.4161/cbt.4.6.1729
Tan JAT, Sun Y, Song J et al (2008) SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem 283:18124–18134. doi:10.1074/jbc.M800512200
Hayashi N, Shirakura H, Uehara T, Nomura Y (2006) Relationship between SUMO-1 modification of caspase-7 and its nuclear localization in human neuronal cells. Neurosci Lett 397:5–9. doi:10.1016/j.neulet.2005.11.057
Houde C, Banks KG, Coulombe N et al (2004) Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J Neurosci 24:9977–9984. doi:10.1523/JNEUROSCI.3356-04.2004
Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276:7320–7326. doi:10.1074/jbc.M008363200
Napirei M, Karsunky H, Zevnik B et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181. doi:10.1038/76032
Kawane K, Fukuyama H, Yoshida H et al (2003) Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol 4:138–144. doi:10.1038/ni881
Croft DR, Coleman ML, Li S et al (2005) Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol 168:245–255. doi:10.1083/jcb.200409049
Martelli AM, Zweyer M, Ochs RL et al (2001) Nuclear apoptotic changes : an overview. J Cell Biochem 82:634–646
Lu CR, Shi Y, Luo Y et al (2010) MAPKs and Mst1/Caspase-3 pathways contribute to H2B phosphorylation during UVB-induced apoptosis. Sci China Life Sci 53:663–668. doi:10.1007/s11427-010-4015-3
Cheung WL, Ajiro K, Samejima K et al (2003) Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113:507–517. doi:10.1016/S0092-8674(03)00355-6
Graves JD, Draves KE, Gotoh Y et al (2001) Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J Biol Chem 276:14909–14915. doi:10.1074/jbc.M010905200
Hu Y, Liu Z, Yang S-J, Ye K (2007) Acinus-provoked protein kinase C delta isoform activation is essential for apoptotic chromatin condensation. Cell Death Differ 14:2035–2046. doi:10.1038/sj.cdd.4402214
Basu A, Akkaraju GR (1999) Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 38:4245–4251. doi:10.1021/bi982854q
Lee KK, Ohyama T, Yajima N et al (2001) MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 276:19276–19285. doi:10.1074/jbc.M005109200
Sahara S, Aoto M, Eguchi Y et al (1999) Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401:168–173. doi:10.1038/43678
Joselin AP, Schulze-Osthoff K, Schwerk C (2006) Loss of Acinus inhibits oligonucleosomal DNA fragmentation but not chromatin condensation during apoptosis. J Biol Chem 281:12475–12484. doi:10.1074/jbc.M509859200
Schwerk C, Prasad J, Degenhardt K et al (2003) ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol Cell Biol 23:2981–2990. doi:10.1128/MCB.23.8.2981
Vucetic Z, Zhang Z, Zhao J et al (2008) Acinus-S’ represses retinoic acid receptor (RAR)-regulated gene expression through interaction with the B domains of RARs. Mol Cell Biol 28:2549–2558. doi:10.1128/MCB.01199-07
Haberman AS, Akbar MA, Ray S, Krämer H (2010) Drosophila acinus encodes a novel regulator of endocytic and autophagic trafficking. Development 137:2157–2166. doi:10.1242/dev.044230
Liu X, Li P, Widlak P et al (1998) The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 95:8461–8466. doi:10.1073/pnas.95.15.8461
Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175–184. doi:10.1016/S0092-8674(00)80197-X
Widlak P, Lanuszewska J, Cary RB, Garrard WT (2003) Subunit structures and stoichiometries of human DNA fragmentation factor proteins before and after induction of apoptosis. J Biol Chem 278:26915–26922. doi:10.1074/jbc.M303807200
Enari M, Sakahira H, Yokoyama H et al (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43–50. doi:10.1038/34112
Widlak P, Li LY, Wang X, Garrard WT (2001) Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem 276:48404–48409. doi:10.1074/jbc.M108461200
Zhang J, Liu X, Scherer DC et al (1998) Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc Natl Acad Sci USA 95:12480–12485. doi:10.1073/pnas.95.21.12480
McIlroy D, Tanaka M, Sakahira H et al (2000) An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev 14:549–558. doi:10.1101/gad.14.5.549
Krieser RJ, MacLea KS, Longnecker DS et al (2002) Deoxyribonuclease IIalpha is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality. Cell Death Differ 9:956–962. doi:10.1038/sj.cdd.4401056
Kawane K, Ohtani M, Miwa K et al (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998–1002. doi:10.2492/inflammregen.29.204
Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95–99. doi:10.1038/35083620
Jayaraj R, Gupta N, Rao PVL (2009) Multiple signal transduction pathways in okadaic acid induced apoptosis in HeLa cells. Toxicology 256:118–127. doi:10.1016/j.tox.2008.11.013
Saelens X, Festjens N, Vande Walle L et al (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23:2861–2874. doi:10.1038/sj.onc.1207523
Arnoult D, Gaume B, Karbowski M et al (2003) Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 22:4385–4399. doi:10.1093/emboj/cdg423
Kalinowska M, Garncarz W, Pietrowska M et al (2005) Regulation of the human apoptotic DNase/RNase endonuclease G: involvement of Hsp70 and ATP. Apoptosis 10:821–830. doi:10.1007/s10495-005-0410-9
Irvine RA, Adachi N, Shibata DK et al (2005) Generation and characterization of endonuclease G null mice. Mol Cell Biol 25:294–302. doi:10.1128/MCB.25.1.294-302.2005
David KK, Sasaki M, Yu S-W et al (2006) EndoG is dispensable in embryogenesis and apoptosis. Cell Death Differ 13:1147–1155. doi:10.1038/sj.cdd.4401787
Susin SA, Lorenzo HK, Zamzami N et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446. doi:10.1038/17135
Baritaud M, Boujrad H, Lorenzo HK et al (2010) Histone H2AX: the missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle 9:3166–3173. doi:10.4161/cc.9.16.12552
Liu KC, Huang YAT, Wu PP et al (2011) The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway. Int J Oncol 38:787–796. doi:10.3892/ijo.2010.894
Joza N, Susin SA, Daugas E et al (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410:549–554. doi:10.1038/35069004
Miramar MD, Costantini P, Ravagnan L et al (2001) NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 276:16391–16398. doi:10.1074/jbc.M010498200
Yuste VJ, Sánchez-López I, Solé C et al (2005) The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis. J Biol Chem 280:35670–35683. doi:10.1074/jbc.M504015200
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078. doi:10.1038/nature08467
Ciccia A, Elledge SJ (2010) The DNA damage response: making it safe to play with knives. Mol Cell 40:179–204. doi:10.1016/j.molcel.2010.09.019
Lou Z, Minter-Dykhouse K, Franco S et al (2006) MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 21:187–200. doi:10.1016/j.molcel.2005.11.025
Dimitrova N, De Lange T (2006) MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres. Genes Dev 20:3238–3243. doi:10.1101/gad.1496606
Goldberg M, Stucki M, Falck J et al (2003) MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421:952–956. doi:10.1038/nature01445
Jazayeri A, Falck J, Lukas C et al (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8:37–45. doi:10.1038/ncb1337
Khoronenkova SV, Dianov GL (2015) ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc Natl Acad Sci USA 112:3997–4002. doi:10.1073/pnas.1416031112
Reinhardt HC, Yaffe MB (2009) Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 21:245–255. doi:10.1016/j.ceb.2009.01.018
Batchelor E, Mock CS, Bhan I et al (2008) Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 30:277–289. doi:10.1016/j.molcel.2008.03.016
Allocati N, Di Ilio C, De Laurenzi V (2012) P63/p73 in the control of cell cycle and cell death. Exp Cell Res 318:1285–1290. doi:10.1016/j.yexcr.2012.01.023
Gurley KE, Kemp CJ (2001) Synthetic lethality between mutation in Atm and DNA-PKcs during murine embryogenesis. Curr Biol 11:191–194. doi:10.1016/S0960-9822(01)00048-3
Stiff T, O’Driscoll M, Rief N et al (2004) ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64:2390–2396. doi:10.1158/0008-5472.CAN-03-3207
Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB (2007) p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11:175–189. doi:10.1016/j.ccr.2006.11.024
Donehower LA, Harvey M, Slagle BL et al (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221. doi:10.1038/356215a0
Murray-Zmijewski F, Slee EA, Lu X (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9:702–712. doi:10.1038/nrm2451
Candeias MM, Malbert-Colas L, Powell DJ et al (2008) P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 10:1098–1105. doi:10.1038/ncb1770
Huang L, Yan Z, Liao X et al (2011) The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci USA 108:12001–12006. doi:10.1073/pnas.1102309108
Hock AK, Vousden KH (2014) The role of ubiquitin modification in the regulation of p53. Biochim Biophys Acta 1843:137–149. doi:10.1016/j.bbamcr.2013.05.022
Lambert PF, Kashanchi F, Radonovich MF et al (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273:33048–33053. doi:10.1074/jbc.273.49.33048
Hu W, Feng Z, Levine AJ (2012) The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer 3:199–208. doi:10.1177/1947601912454734
Espinosa JM (2008) Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene 27:4013–4023. doi:10.1038/onc.2008.37
Tang Y, Luo J, Zhang W, Gu W (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24:827–839. doi:10.1016/j.molcel.2006.11.021
Reed SM, Quelle DE (2015) p53 acetylation: regulation and consequences. Cancers (Basel) 7:30–69. doi:10.3390/cancers7010030
Le Guezennec X, Bulavin DV (2010) WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci 35:109–114. doi:10.1016/j.tibs.2009.09.005
Ling H, Peng L, Seto E, Fukasawa K (2012) Suppression of centrosome duplication and amplifcation by deacetylases. Cell Cycle 11:3779–3791. doi:10.4161/cc.21985
Kon N, Kobayashi Y, Li M et al (2010) Inactivation of HAUSP in vivo modulates p53 function. Oncogene 29:1270–1279. doi:10.1038/onc.2009.427
Bhattacharya S, Ghosh MK (2014) Cell death and deubiquitinases: perspectives in cancer. Biomed Res Int 2014:435197. doi:10.1155/2014/435197
Zhang Y, Gao Y, Zhang G et al (2011) DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells. Int J Cancer 128:551–561. doi:10.1002/ijc.25365
Muñoz-Espín D, Cañamero M, Maraver A et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155:1104–1118. doi:10.1016/j.cell.2013.10.019
Storer M, Mas A, Robert-Moreno A et al (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell. doi:10.1016/j.cell.2013.10.041
Hayward RL, Macpherson JS, Cummings J et al (2003) Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Clin Cancer Res 9:2856–2865
Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030–9040. doi:10.1038/sj.onc.1207116
He L, He X, Lim LP et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134. doi:10.1038/nature05939
Olivier M, Eeles R, Hollstein M et al (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607–614. doi:10.1002/humu.10081
Marchenko ND, Wolff S, Erster S et al (2007) Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26:923–934. doi:10.1038/sj.emboj.7601560
Wolff S, Erster S, Palacios G, Moll UM (2008) p53’s mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 18:733–744. doi:10.1038/cr.2008.62
Giorgi C, Bonora M, Missiroli S et al (2015) Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget 6:1435–1445
Giorgi C, Bonora M, Sorrentino G et al (2015) p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc Natl Acad Sci 112:1779–1784. doi:10.1073/pnas.1410723112
Zhang Y, Lu H (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell 16:369–377. doi:10.1016/j.ccr.2009.09.024
Zhou X, Liao W, Liao J et al (2015) Ribosomal proteins : functions beyond the ribosome. J Mol Cell Biol 7:92–104. doi:10.1093/jmcb/mjv014
Zhou X, Liao J-M, Liao W-J, Lu H (2012) Scission of the p53-MDM2 loop by ribosomal proteins. Genes Cancer 3:298–310. doi:10.1177/1947601912455200
Cui D, Li L, Lou H et al (2014) The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene 33:2225–2235. doi:10.1038/onc.2013.170
Ono W, Hayashi Y, Yokoyama W et al (2014) The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption. J Biol Chem 289:4928–4940. doi:10.1074/jbc.M113.474049
Sasaki M, Kawahara K, Nishio M et al (2011) Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med 17:944–951. doi:10.1038/nm.2392
Lee S, Kim J-Y, Kim Y-J et al (2012) Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ 19:1613–1622. doi:10.1038/cdd.2012.40
Donati G, Peddigari S, Mercer CA, Thomas G (2013) 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep 4:87–98. doi:10.1016/j.celrep.2013.05.045
Sloan KE, Bohnsack MT, Watkins NJ (2013) The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep 5:237–247. doi:10.1016/j.celrep.2013.08.049
Kim J-Y, Cho Y-E, An Y-M et al (2015) GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer. J Cell Mol Med 19:1245–1252. doi:10.1111/jcmm.12474
Kim T, Leslie P, Zhang Y (2014) Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability. Oncotarget 5:860–871
Chakraborty A, Uechi T, Higa S et al (2009) Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS ONE 4(1):e4152. doi:10.1371/journal.pone.0004152
Barna M, Pusic A, Zollo O et al (2008) Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456:971–975. doi:10.1038/nature07449
Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8:1006–1016. doi:10.1038/nrm2277
Wang ZG, Ruggero D, Ronchetti S et al (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20:266–272. doi:10.1038/3073
Lallemand-Breitenbach V, de Thé H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a000661
Van Damme E, Laukens K, Dang TH, van Ostade X (2010) A manually curated network of the pml nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci 6:51–67. doi:10.7150/ijbs.6.51
De Stanchina E, Querido E, Narita M et al (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13:523–535. doi:10.1016/S1097-2765(04)00062-0
Knippschild U, Gocht A, Wolff S et al (2005) The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal 17:675–689. doi:10.1016/j.cellsig.2004.12.011
Bernardi R, Papa A, Pandolfi PP (2008) Regulation of apoptosis by PML and the PML-NBs. Oncogene 27:6299–6312. doi:10.1038/onc.2008.305
Sombroek D, Hofmann TG (2009) How cells switch HIPK2 on and off. Cell Death Differ 16:187–194. doi:10.1038/cdd.2008.154
Li Q, He Y, Wei L et al (2011) AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation. Oncogene 30:1194–1204. doi:10.1038/onc.2010.499
Li Q, Wang X, Wu X, Rui Y, Liu W, Wang J et al (2007) Daxx cooperates with the axin/HIPK2/p53 complex to induce cell death. Cancer Res 67:66–74. doi:10.1158/0008-5472.CAN-06-1671
Li Q, Lin S, Wang X et al (2009) Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat Cell Biol 11:1128–1134. doi:10.1038/ncb1927
Krieghoff-Henning E, Hofmann TG (2008) Role of nuclear bodies in apoptosis signalling. Biochim Biophys Acta 1783:2185–2194. doi:10.1016/j.bbamcr.2008.07.002
Morgan M, Thorburn J, Pandolfi PP, Thorburn A (2002) Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol 157:975–984. doi:10.1083/jcb.200204039
Condemine W, Takahashi Y, Zhu J et al (2006) Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66:6192–6198. doi:10.1158/0008-5472.CAN-05-3792
Yang A, Schweitzer R, Sun D et al (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718. doi:10.1038/19539
Levine AJ, Tomasini R, McKeon FD et al (2011) The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 12:259–265. doi:10.1038/nrm3086
Yoon M, Ha J, Lee M (2015) Structure and apoptotic function of p73. BMB Rep 48:81–90. doi:10.5483/BMBRep.48.2.255
Rossi M, De Laurenzi V, Munarriz E et al (2005) The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 24:836–848. doi:10.1038/sj.emboj.7600444
Rossi M, Aqeilan RI, Neale M et al (2006) The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci USA 103:12753–12758. doi:10.1073/pnas.0603449103
Vilgelm A, El-Rifai W, Zaika A (2008) Therapeutic prospects for p73 and p63: rising from the shadow of p53. Drug Resist Updat 11:152–163. doi:10.1016/j.drup.2008.08.001
Gressner O, Schilling T, Lorenz K et al (2005) TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 24:2458–2471. doi:10.1038/sj.emboj.7600708
Busuttil V, Droin N, McCormick L et al (2010) NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2. Proc Natl Acad Sci USA 107:18061–18066. doi:10.1073/pnas.1006163107
Boominathan L (2010) The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev 29:613–639. doi:10.1007/s10555-010-9257-9
Amelio I, Grespi F, Annicchiarico-Petruzzelli M, Melino G (2012) p63 the guardian of human reproduction. Cell Cycle 11:4545–4551. doi:10.4161/cc.22819
Bolcun-Filas E, Rinaldi VD, White ME, Schimenti JC (2014) Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science 343:533–536. doi:10.1126/science.1247671
Jones EV, Dickman MJ, Whitmarsh AJ (2007) Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J 405:617–623. doi:10.1042/BJ20061778
Conforti F, Sayan AE, Sreekumar R, Sayan BS (2012) Regulation of p73 activity by post-translational modifications. Cell Death Dis 3:e285. doi:10.1038/cddis.2012.27
Ben-Yehoyada M, Ben-Dor I, Shaul Y (2003) c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. J Biol Chem 278:34475–34482. doi:10.1074/jbc.M301051200
Goldberg Z, Sionov RV, Berger M et al (2002) Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J 21:3715–3727. doi:10.1093/emboj/cdf384
Zuckerman V, Lenos K, Popowicz GM et al (2009) c-Abl phosphorylates Hdmx and regulates its interaction with p53. J Biol Chem 284:4031–4039. doi:10.1074/jbc.M809211200
Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27:6245–6251. doi:10.1038/onc.2008.301
Wang X, Zeng L, Wang J et al (2011) A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ 18:5–15. doi:10.1038/cdd.2010.106
Reuven N, Adler J, Porat Z et al (2015) The tyrosine kinase c-Abl promotes homeodomain-interacting protein kinase 2 (HIPK2) accumulation and activation in response to DNA damage. J Biol Chem 290:16478–16488. doi:10.1074/jbc.M114.628982
Zhou X, Hao Q, Zhang Q et al (2014) Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition. Cell Death Differ 22:755–766. doi:10.1038/cdd.2014.167
Salomoni P, Dvorkina M, Michod D (2012) Role of the promyelocytic leukaemia protein in cell death regulation. Cell Death Dis 3:e247-6. doi:10.1038/cddis.2011.122
Lapi E, Di Agostino S, Donzelli S et al (2008) PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 32:803–814. doi:10.1016/j.molcel.2008.11.019
Joerger AC, Rajagopalan S, Natan E et al (2009) Structural evolution of p53, p63, and p73: implication for heterotetramer formation. Proc Natl Acad Sci USA 106:17705–17710. doi:10.1073/pnas.0905867106
Haupt S, Di Agostino S, Mizrahi I et al (2009) Promyelocytic leukemia protein is required for gain of function by mutant p53. Cancer Res 69:4818–4826. doi:10.1158/0008-5472.CAN-08-4010
Haupt S, Mitchell C, Corneille V et al (2013) Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle 12:1722–1731. doi:10.4161/cc.24805
Gurrieri C, Capodieci P, Bernardi R et al (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269–279. doi:10.1093/jnci/djh043
Bernassola F, Oberst A, Melino G, Pandolfi PP (2005) The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63. Oncogene 24:6982–6986. doi:10.1038/sj.onc.1208843
Tomlinson V, Gudmundsdottir K, Luong P et al (2010) JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis 1:e29. doi:10.1038/cddis.2010.7
Yang X, Khosravi-Far R, Chang HY, Baltimore D (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067–1076. doi:10.1016/S0092-8674(00)80294-9
Torii S, Egan DA, Evans RA, Reed JC (1999) Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 18:6037–6049. doi:10.1093/emboj/18.21.6037
Croxton R, Puto LA, De Belle I et al (2006) Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB. Cancer Res 66:9026–9035. doi:10.1158/0008-5472.CAN-06-1047
Lindsay CR, Morozov VM, Ishov AM (2008) PML NBs (ND10) and Daxx: from nuclear structure to protein function. Front Biosci 13:7132–7142. doi:10.2741/3216
Lindsay CR, Giovinazzi S, Ishov AM (2009) Daxx is a predominately nuclear protein that does not translocate to the cytoplasm in response to cell stress. Cell Cycle 8:1544–1551. doi:10.4161/cc.8.10.8379
Tanaka M, Kamitani T (2010) Cytoplasmic relocation of Daxx induced by Ro52 and FLASH. Histochem Cell Biol 134:297–306. doi:10.1007/s00418-010-0734-6
Michaelson JS, Bader D, Frank K et al (1999) Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev 13:1918–1923. doi:10.1101/gad.13.15.1918
Ishov AM, Vladimirova OV, Maul GG (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 117:3807–3820. doi:10.1242/jcs.01230
Salomoni P (2013) The PML-interacting protein DAXX: histone loading gets into the picture. Front Oncol 3:152. doi:10.3389/fonc.2013.00152
Imai Y, Kimura T, Murakami A et al (1999) The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398:777–785. doi:10.1038/19709
Milovic-Holm K, Krieghoff E, Jensen K et al (2007) FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J 26:391–401. doi:10.1038/sj.emboj.7601504
Chen S, Evans HG, Evans DR (2012) FLASH knockdown sensitizes cells to Fas-mediated apoptosis via down-regulation of the anti-apoptotic proteins, MCL-1 and cflip short. PLoS ONE 7(3):e32971. doi:10.1371/journal.pone.0032971
De Cola A, Bongiorno-Borbone L, Bianchi E et al (2011) FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription. Oncogene. doi:10.1038/onc.2011.274
Vennemann A, Hofmann TG (2013) SUMO regulates proteasome-dependent degradation of FLASH/Casp8AP2. Cell Cycle 12:1914–1921. doi:10.4161/24943
Wu W-S, Xu Z-X, Ran R et al (2002) Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene 21:3925–3933. doi:10.1038/sj.onc.1205491
Li H, Kolluri SK, Gu J et al (2000) Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289:1159–1164. doi:10.1126/science.289.5482.1159
Kolluri SK, Zhu X, Zhou X et al (2008) A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14:285–298. doi:10.1016/j.ccr.2008.09.002
Zhou Y, Zhao W, Xie G et al (2014) Induction of Nur77-dependent apoptotic pathway by a coumarin derivative through activation of JNK and p38 MAPK. Carcinogenesis 35:2660–2669. doi:10.1093/carcin/bgu186
Wang W, Wang Y, Chen H et al (2014) Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat Chem Biol 10:133–140. doi:10.1038/nchembio.1406
Giorgi C, Ito K, Lin H-K et al (2010) PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330:1247–1251. doi:10.1126/science.1189157
Ichim G, Lopez J, Ahmed SU et al (2015) Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell 57:860–872. doi:10.1016/j.molcel.2015.01.018
Liu X, He Y, Li F et al (2015) Caspase-3 promotes genetic instability and carcinogenesis. Mol Cell 58:284–296. doi:10.1016/j.molcel.2015.03.003
Tang HL, Tang HM, Mak KH et al (2012) Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell 23:2240–2252. doi:10.1091/mbc.E11-11-0926
Acknowledgments
This work was supported by Grant from the Russian Science Foundation (14-25-0056). The work in the authors’ laboratories is also supported by Grants from the Russian Foundation for Basic Research, Russian President Fund, Dynasty Foundation, as well as the Stockholm and Swedish Cancer Societies, the Swedish Childhood Cancer Foundation, and the Swedish Research Council. We apologize to those authors whose primary works could not be cited owing to space limitations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prokhorova, E.A., Zamaraev, A.V., Kopeina, G.S. et al. Role of the nucleus in apoptosis: signaling and execution. Cell. Mol. Life Sci. 72, 4593–4612 (2015). https://doi.org/10.1007/s00018-015-2031-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-015-2031-y